Heres wot im struggling with.
Riken cancelled the first ipsc human trial becoz of batch discrepancies in the autologous material...restarted trial using allogeneic material.
How did temcell manage to mass produce off the shelf consistant quality allogeneic mscs?.
Cymerus is the only mass produceable consistant quality mscs in the world we are told.
So how does temcell product do it??
Fuji wouldnt have bought in unless they understood this...i suspect one companys silver lining is another companys cumulus nimbus!!
Exciting times for Cynata me thinks.....
Heres wot im struggling with. Riken cancelled the first ipsc...
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.01M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12223 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 6089 | 2 |
View Market Depth
| Last trade - 10.02am 15/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable